封面
市場調查報告書
商品編碼
2050741

全球多體學市場:按產品/服務、類型、平台、應用、最終用戶和地區分類

Global Multiomics Market, By Product & Service, By Type, By Platform, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 154 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球多組體學市場預計在2026年達到28.6億美元,預計2033年將達到78.8億美元。預計從2026年到2033年,其複合年成長率將達到15.6%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 28.6億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 15.60% 2033年市場規模預測: 78.8億美元

多體學是指一種整合多種體學技術(例如基因組學、表觀基因、轉錄組學、蛋白質組學和代謝體學)的綜合體學方法,旨在全面深入了解生物系統。透過整合多層生物數據,多組體學相比單一體學方法能夠更深入地理解分子機制、通道和網路。這使得研究人員能夠更全面地整體情況生物過程和表現型。隨著人們逐漸認知到整合體學策略在健康和疾病研究中的潛力,多組體學市場正在快速成長。實驗技術、生物資訊學工具和計算能力的進步進一步加速了多體學在生物醫學研究中的應用。

市場動態:

多組體學在個人化醫療、藥物發現和藥物開發領域的日益普及,是未來幾年推動多體學市場成長的關鍵因素之一。在個人化醫療領域,多組體學方法正被擴大用於基於患者分子譜開發有效的個人化治療方法。製藥公司也在利用多組體學來識別新的藥物標靶和生物標記,並開發精準醫療。然而,大型複雜多組體學資料集帶來的資料整合和管理挑戰,以及缺乏全面的分析工具,預計將會抑制市場成長。開發方便用戶使用的數據分析解決方案、標準化數據處理工作流程以及建立體學數據存儲庫,預計將在預測期內為多體學市場參與者創造廣泛的發展機會。

本研究的主要特點:

  • 本研究確定了各細分市場的潛在收入成長機會,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據以下參數對全球多體學市場的主要參與者進行了分析:公司亮點、產品系列、主要特徵、財務表現和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球多體學市場報告面向產業內的各種相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 透過各種用於分析全球多體學市場的策略矩陣,相關人員將能夠更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 擴大多體學在個人化醫療的應用
    • 擴大多體學研究的投資和資金籌措
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 服務提供組合
  • PEST分析
  • 波特的分析
  • 併購情景
  • 管道分析

第4章 全球多元體學市場:依產品與服務分類,2021-2033年

  • 產品
  • 服務

第5章 全球多組體學市場:按類型分類,2021-2033年

  • 單細胞多組體學
  • 批量多體學

第6章 全球多元組體學市場:依平台分類,2021-2033年

  • 基因組學
  • 轉錄組學
  • 蛋白質體學
  • 代謝體學
  • 整合組體學平台

第7章 全球多元體學市場:依應用領域分類,2021-2033年

  • 診斷
  • 藥物發現和藥物開發
  • 個人化醫療
  • AgriGenomics
  • 其他(環境監測等)

第8章 全球多組體學市場:依最終用戶分類,2021-2033年

  • 製藥和生物技術公司
  • 學術研究機構
  • 臨床研究機構(CRO)
  • 其他(醫院和診斷中心等)

第9章 全球多組體學市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第10章 競爭格局

  • BD
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc
  • Danaher, PerkinElmer Inc.
  • Shimadzu Corporation
  • Bruker
  • QIAGEN
  • Agilent Technologies, Inc.
  • BGI

第11章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI6633

Global Multiomics Market is estimated to be valued at USD 2.86 Bn in 2026 and is expected to reach USD 7.88 Bn by 2033, growing at a compound annual growth rate (CAGR) of 15.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 2.86 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 15.60% 2033 Value Projection: USD 7.88 Bn

Multiomics refers to the integrated omics approach that combines diverse omic technologies such as genomics, epigenomics, transcriptomics, proteomics, and metabolomics to obtain comprehensive insights into biological systems. By integrating multiple layers of biological data, multiomics facilitates a deeper understanding of molecular mechanisms, pathways, and networks compared to single-omics approaches. It allows researchers to gain a more complete picture of biological processes and phenotypes. The multiomics market is growing rapidly as researchers realize the potential of integrated omics strategies to study health and disease. Advancements in experimental techniques, bioinformatics tools, and computing power are further accelerating the application of multiomics in biomedical research.

Market Dynamics:

The growing adoption of multiomics in personalized medicine, drug discovery, and development are some of the key factors expected to drive the growth of the multiomics market in the coming years. Multiomics approaches are increasingly being used in personalized medicine to develop effective, individualized treatments based on a patient's molecular profile. Pharmaceutical companies are also leveraging multiomics to identify novel drug targets and biomarkers and develop precision therapeutics. However, data integration and management challenges posed by large and complex multiomics datasets as well as lack of comprehensive analytical tools are some of the factors expected to restrain the market growth. Development of user-friendly data analysis solutions, standardization of data processing workflows, and establishment of omics data repositories could create lucrative opportunities for multiomics market players over the forecast period.

Key Features of the Study:

  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global multiomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include BD, Thermo Fisher Scientific Inc., Illumina, Inc, Danaher, PerkinElmer Inc., Shimadzu Corporation, Bruker, QIAGEN, Agilent Technologies, Inc., and BGI.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global multiomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global multiomics market.

Detailed Segmentation:

  • Global Multiomics Market, By Product & Service (Revenue, USD Bn, 2021 - 2033)
  • Products
    • Instruments
    • Consumables
    • Software
  • Services
  • Global Multiomics Market, By Type (Revenue, USD Bn, 2021 - 2033)
  • Single-cell Multiomics
  • Bulk Multiomics
  • Global Multiomics Market, By Platform (Revenue, USD Bn, 2021 - 2033)
  • Genomics
  • Transcriptomics
  • Proteomics
  • Metabolomics
  • Integrated Omics Platforms
  • Global Multiomics Market, By Application (Revenue, USD Bn, 2021 - 2033)
  • Diagnostics
  • Drug Discovery and Development
  • Personalized Medicine
  • AgriGenomics
  • Others (Environmental Monitoring, etc.)
  • Global Multiomics Market, By End User (Revenue, USD Bn, 2021 - 2033)
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Clinical Research Organizations (CROs)
  • Others (Hospitals and Diagnostic Centers, etc.)
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Global Multiomics Market, Key Players
  • BD
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc
  • Danaher, PerkinElmer Inc.
  • Shimadzu Corporation
  • Bruker
  • QIAGEN
  • Agilent Technologies, Inc.
  • BGI

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Multiomics Market, By Product & Service
    • Global Multiomics Market, By Type
    • Global Multiomics Market, By Platform
    • Global Multiomics Market, By Application
    • Global Multiomics Market, By End User
    • Global Multiomics Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing usage of multiomics in personalized medicine
    • Growing investment in and funding of multiomics research
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Service Offering Portfolio
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Pipeline Analysis

4. Global Multiomics Market, By Product & Service, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
      • Instruments
      • Consumables
      • Software
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

5. Global Multiomics Market, By Type, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Single-cell Multiomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Bulk Multiomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

6. Global Multiomics Market, By Platform, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Genomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Transcriptomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Proteomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Metabolomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Integrated Omics Platforms
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

7. Global Multiomics Market, By Application, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Drug Discovery and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Personalized Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • AgriGenomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Others (Environmental Monitoring, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

8. Global Multiomics Market, By End User, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Clinical Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Others (Hospitals and Diagnostic Centers, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

9. Global Multiomics Market, By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021 - 2033, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • BD
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Illumina, Inc
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Danaher, PerkinElmer Inc.
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Shimadzu Corporation
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bruker
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • QIAGEN
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BGI
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us